Pairing a GLP-1 drug with another treatment could help people with psoriasis, The Hill reports. Tap through for the details on the research.
Recap by typeshit. Full story at The Hill.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
Shah points to research published September 2 in which older mice given semaglutide lived longer, with effects he says went beyond blood sugar control.
The review weighs weight and metabolic benefits in people with IBD against early lab hints of anti-inflammatory effects, and looks at what observational studies show so far.
The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
Andrew Huberman and neuroscientist Scott Kanoski cover how food choices affect memory and cravings, with early chapters on natural GLP-1 and the drugs.
A short clip about spotting something white inside a peptide vial. Few details beyond the title, so it's unclear what the creator concludes.
Loading…